Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-101 in Dry Eye Disease
NCT01478555Phase 2Withdrawn
- Sponsor
- Sun Pharma
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of bromfenac sodium in dry eye disease (DED), sponsored by Sun Pharma. Planned start Jan 2018; status: withdrawn.
02
Drugs
bromfenac sodium
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01478555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478555.